Review
Published on 28 Oct 2021
Immune Evasion Mechanism and AXL
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.756225
- 11,288 views
- 24 citations
Type at least 3 characters
1,009 articles
Articles
Original Research
Published on 27 Oct 2021
HMGB1 Promotes Resistance to Doxorubicin in Human Hepatocellular Carcinoma Cells by Inducing Autophagy via the AMPK/mTOR Signaling Pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.739145
- 3,408 views
- 24 citations
Mini Review
Published on 26 Oct 2021
Therapeutic Targeting of Cancer: Epigenetic Homeostasis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.747022
- 3,866 views
- 14 citations
Review
Published on 25 Oct 2021
Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An Update
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.733652
- 15,225 views
- 57 citations
Case Report
Published on 25 Oct 2021
Case Report: Osimertinib Followed by Osimertinib Plus Bevacizumab, Personalized Treatment Strategy for a Lung Cancer Patient With a Novel EGFR Exon 20 Insertion D770_N771insGT and Multiple Brain Metastases
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.733276
- 4,464 views
- 3 citations
Original Research
Published on 25 Oct 2021
Achieving NIR Light-Mediated Tumor-Specific Fenton Reaction-Assisted Oncotherapy by Using Magnetic Nanoclusters
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.777295
- 1,830 views
- 1 citation
Original Research
Published on 22 Oct 2021
LncRNA OTUD6B-AS1 Induces Cisplatin Resistance in Cervical Cancer Cells Through Up-Regulating Cyclin D2 via miR-206
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.777220
- 2,553 views
- 15 citations
Review
Published on 22 Oct 2021
Radioimmunotherapy Combined With Low-Intensity Ultrasound and Microbubbles: A Potential Novel Strategy for Treatment of Solid Tumors
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.750741
- 3,119 views
- 3 citations
Review
Published on 22 Oct 2021
Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.772915
- 9,437 views
- 37 citations
Original Research
Published on 21 Oct 2021
Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.745590
- 4,962 views
- 6 citations
Original Research
Published on 21 Oct 2021
Long Noncoding RNA KLF3-AS1 Acts as an Endogenous RNA of miR-223 to Attenuate Gastric Cancer Progression and Chemoresistance
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.704339
- 1,932 views
- 7 citations
Original Research
Published on 21 Oct 2021
Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.757196
- 3,488 views
- 16 citations
Case Report
Published on 20 Oct 2021
Efficacy of Cyproheptadine Monotherapy in Hepatocellular Carcinoma With Bone Metastasis: A Case Report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.620212
- 4,560 views
- 1 citation
Original Research
Published on 20 Oct 2021
SnFe2O4 Nanozyme Based TME Improvement System for Anti-Cancer Combination Thermoradiotherapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.768829
- 2,461 views
- 4 citations
Review
Published on 19 Oct 2021
Nanozymes in Tumor Theranostics
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.666017
- 7,199 views
- 27 citations
Case Report
Published on 15 Oct 2021
Neuromuscular Complications of Targeted Anticancer Agents: Can Tyrosine Kinase Inhibitors Induce Myasthenia Gravis? Getting Answers From a Case Report up to a Systematic Review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2021.727010
- 5,878 views
- 2 citations